Richter j e, peura d, benjamin s b, joelsson b & whipple j efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis arch intern med 160, 1810–1816 (2000). Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis. The primary treatment goals in patients with gastroesophageal reflux disease are relief of symptoms, prevention of symptom relapse, healing of erosive esophagitis, and prevention of complications.
efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis
We therefore performed a trial called "gaviscon ® vs omeprazole in symptomatic treatment of moderate gastroesophageal reflux" (good), the aim of which was to compare short-term symptomatic efficacy and safety between an alginate (gaviscon ®, 4 × 10 ml/day) and a ppi (omeprazole 20 mg/day) in moderate gerd in a general practice setting. Gastroesophageal reflux disease (gerd) has been defined as chronic symptoms or mucosal damage produced by the abnormal reflux of gastric contents into the esophagus. 1 the cardinal manifestation of gerd, heartburn, is experienced monthly by approximately 25% of adults in developed countries, while at least 5% have it daily. 2 – 6 such patients experience a decreased quality of life. 7. Omeprazole is a proton-pump inhibitor indicated for gastroesophageal reflux disease and erosive esophagitis treatment in children. the aim of this review was to evaluate the efficacy of delayed-release oral suspension of omeprazole in childhood esophagitis, in terms of symptom relief, reduction in reflux index and/or intragastric acidity, and endoscopic and/or histological healing..
